GLG Partners’s Lombard Medical, Inc. EVAR Stock Holding History

GLG Partners’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,892	Closed	-$84K	–	535
2015 Q1	$84K	Sell	20,892 -40,000	-66%	-$206K	﹤0.01%	374
2014 Q4	$396K	Hold	60,892	–	–	0.01%	343
2014 Q3	$468K	Hold	60,892	–	–	0.01%	372
2014 Q2	$438K	Buy	+60,892	New	+$496K	0.01%	342

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GLG Partners's EVAR Position: Q2 2015 in Review

GLG Partners sold out of Lombard Medical, Inc. (EVAR) in Q2 2015, closing a stake of 20,892 shares — an estimated $84K sold.

GLG Partners first reported a position in EVAR in Q2 2014 and held it in 4 quarters. The position peaked at $468K in Q3 2014. 17 funds tracked by Wall St. Rank hold EVAR as of Q2 2015.

GLG Partners reported no remaining Lombard Medical, Inc. position as of Q2 2015 after selling out during the quarter.
GLG Partners sold 20,892 Lombard Medical, Inc. shares in Q2 2015, an estimated $84K.
GLG Partners first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 4 quarters.
GLG Partners's Lombard Medical, Inc. position peaked at $468K in Q3 2014.
17 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q2 2015.

Based on GLG Partners's 13F filing for Q2 2015, filed 14 Aug 2015.